News

A precise description of the clinical subtypes of multiple sclerosis is necessary in order to better classify each patient’s disease and better tailor their immunomodulatory therapy according to its course.

Why does a person with a particular predisposition due to hereditary genetic factors develop the disease at all? Lies Van Horebeek proposes a novel explanation in her research project...

In recent years, it has been shown that starting treatment early in MS patients significantly improves the long-term prognosis in the relapsing-remitting forms. It is therefore critically important that MS be diagnosed as soon as possible...

Share your joy and start your action to fund research days through your event. Every opportunity to celebrate is an opportunity to support research.

The theme this year is 'Research'. In Belgium, the Belgian Charcot Foundation guarantees quality and continuity for more than 30 years with more than 200 researchers from the 23 recognized research centers.

The excellence of Belgian researchers and the great care that the Fonds Charcot jury takes in selecting research projects make it possible to support innovative projects with concrete results.

Every opportunity to celebrate is an opportunity to support research. Share your joy and take action to defeat multiple sclerosis.

The 20km edition of Brussels 2018 is a success, 98 runners and more than 20,000 euros for the MS Research.

Run or sponsor! Fill in your inscription today and join the Charcot Team during the 20km off Brussels on May 27, 2018. It will be a perfect day and you will be helping the MS-Research. 12 000 patients are counting on this research and thank you.

Ideally, physical activity should be started as soon as the disease is diagnosed and continued uninterrupted.

Every month a laureate of the Charcot Fond 2018 presents him or herself... This month : Prof. Dr. Vincent van Pesch

The laureates of the Charcot Fund 2018 are known: a choice for concrete results, a focus on progressive MS and, as usual, support for innovative basic research.